Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Saudi Arabia has opened its real estate market to foreign buyers, including eligible Indians, through a new ownership ...

Saudi Arabia stressed before the United Nations Security Council on Tuesday its support for the unity, sovereignty, and ...

Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud sent on Tuesday a cable of condolence and sympathy to ...

Patients with previously treated metastatic pancreatic cancer lived roughly twice as long on a daily oral drug called daraxonrasib compared with standard chemotherapy, according to results from a ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...

Please provide your email address to receive an email when new articles are posted on . Daraxonrasib doubled OS and PFS compared with chemotherapy for previously treated metastatic pancreatic cancer.

This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a full text component.

Be careful what you wish for. This idea, often explored in fiction, lies at the center of “Obsession,” Focus Features‘ new horror film from writer/director/editor Curry Barker. The movie follows Bear ...

Their sexual orientation or gender identity forces most of them to dire states of difficulty. For many others, it is protection visas becoming almost the only true lifeline for those in need of safety ...